PubMed

Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control.

Gokcel A, Karakose H, Ertorer EM, Tanaci N, Tutuncu NB, Guvener N.

Diabetes Care. 2001 Nov;24(11):1957-60.PMID: 11679464 [PubMed - indexed for MEDLINE]Related articlesFree article

Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.

Derosa G, Mereu R, Salvadeo SA, D'Angelo A, Ciccarelli L, Piccinni MN, Ferrari I, Gravina A, Maffioli P, Cicero AF.

Intern Med. 2009;48(5):265-71. Epub 2009 Mar 2.PMID: 19252346 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.

Gokcel A, Gumurdulu Y, Karakose H, Melek Ertorer E, Tanaci N, BascilTutuncu N, Guvener N.

Diabetes Obes Metab. 2002 Jan;4(1):49-55.PMID: 11874442 [PubMed - indexed for MEDLINE]Related articles

Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.

Wang TF, Pei D, Li JC, Tsai WC, Tsai CC, Yao CY, Chang ET, Hsieh MC, Su KY, Kuo SW.

Int J Clin Pract. 2005 Jul;59(7):746-50.PMID: 15963197 [PubMed - indexed for MEDLINE]Related articles

[Pharmacological therapy of obesity]

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.

Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.

Metabolism. 2008 Nov;57(11):1552-7.PMID: 18940393 [PubMed - indexed for MEDLINE]Related articles

Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy.

Serrano-Rios M, Melchionda N, Moreno-Carretero E; Spanish Investigators.

Diabet Med. 2002 Feb;19(2):119-24.PMID: 11874427 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin.

McNulty SJ, Ur E, Williams G; Multicenter Sibutramine Study Group.

Diabetes Care. 2003 Jan;26(1):125-31.PMID: 12502668 [PubMed - indexed for MEDLINE]Related articlesFree article

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

Diabetes Obes Metab. 2000 Jun;2(3):175-87.PMID: 11220553 [PubMed - indexed for MEDLINE]Related articles

Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

Clin Ther. 2004 Sep;26(9):1427-35.PMID: 15531005 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.

McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, Mooradian AD.

Arch Intern Med. 2000 Jul 24;160(14):2185-91.PMID: 10904462 [PubMed - indexed for MEDLINE]Related articlesFree article

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

Diabetes Obes Metab. 2000 Apr;2(2):105-12.PMID: 11220522 [PubMed - indexed for MEDLINE]Related articles

Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes.

Kaukua JK, Pekkarinen TA, Rissanen AM.

Int J Obes Relat Metab Disord. 2004 Apr;28(4):600-5.PMID: 14770192 [PubMed - indexed for MEDLINE]Related articles

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

Roberts VL, Stewart J, Issa M, Lake B, Melis R.

Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.

Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.

Diabetes Nutr Metab. 2004 Aug;17(4):222-9.PMID: 15575343 [PubMed - indexed for MEDLINE]Related articles

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

Clin Ther. 2004 May;26(5):744-54.PMID: 15220018 [PubMed - indexed for MEDLINE]Related articles

Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study.

Lam KS, Tiu SC, Tsang MW, Ip TP, Tam SC.

Diabetes Care. 1998 Jul;21(7):1154-8.PMID: 9653611 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.

J Hum Hypertens. 2002 Jan;16(1):13-9.PMID: 11840225 [PubMed - indexed for MEDLINE]Related articlesFree article

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.

McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K; Sibutramine in Hypertensives Clinical Study Group.

J Hum Hypertens. 2002 Jan;16(1):5-11.PMID: 11840224 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.

García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.

Clin Ther. 2006 May;28(5):770-82.PMID: 16861099 [PubMed - indexed for MEDLINE]Related articles